Interleukin-5, eosinophils, and disease - PubMed (original) (raw)
Review
. 1992 Jun 15;79(12):3101-9.
Affiliations
- PMID: 1596561
Free article
Review
Interleukin-5, eosinophils, and disease
C J Sanderson. Blood. 1992.
Free article
No abstract available
Similar articles
- Airway hyperresponsiveness: first eosinophils and then neuropeptides.
Kraneveld AD, Folkerts G, Van Oosterhout AJ, Nijkamp FP. Kraneveld AD, et al. Int J Immunopharmacol. 1997 Sep-Oct;19(9-10):517-27. doi: 10.1016/s0192-0561(97)00085-4. Int J Immunopharmacol. 1997. PMID: 9637348 Review. - Eosinophils and the lung.
Bertorelli G, Pesci A. Bertorelli G, et al. Monaldi Arch Chest Dis. 1994 Jun;49(3):221-6. Monaldi Arch Chest Dis. 1994. PMID: 8087119 Review. - Interleukin-5: a proeosinophil cytokine mediator of inflammation in asthma and a target for antisense therapy.
Weltman JK, Karim AS. Weltman JK, et al. Allergy Asthma Proc. 1998 Sep-Oct;19(5):257-61. doi: 10.2500/108854198778557782. Allergy Asthma Proc. 1998. PMID: 9801738 Review. - Eosinophils negatively regulate eosinophilopoiesis by decreasing IL-5 levels.
Enokihara H, Koike T, Nakamura Y, Yamashiro K, Tsuruoka N, Saito K, Furusawa S. Enokihara H, et al. Int Arch Allergy Immunol. 1996;111 Suppl 1:2-4. doi: 10.1159/000237403. Int Arch Allergy Immunol. 1996. PMID: 8906102 - Eosinophils, eosinophilic cytokines (interleukin-5), and antieosinophilic therapy in asthma.
Menzies-Gow A, Robinson DS. Menzies-Gow A, et al. Curr Opin Pulm Med. 2002 Jan;8(1):33-8. doi: 10.1097/00063198-200201000-00006. Curr Opin Pulm Med. 2002. PMID: 11753121 Review.
Cited by
- Long-term effects of mepolizumab in patients with severe eosinophilic asthma: a 6-year real-life experience.
Stanziola AA, Candia C, Nazzaro G, Caso A, Merola C, Gallotti L, Maniscalco M. Stanziola AA, et al. Front Pharmacol. 2024 Aug 8;15:1449220. doi: 10.3389/fphar.2024.1449220. eCollection 2024. Front Pharmacol. 2024. PMID: 39175541 Free PMC article. - A Potential Role of Interleukin-5 in the Pathogenesis and Progression of Amyotrophic Lateral Sclerosis: A New Molecular Perspective.
Moțățăianu A, Andone S, Stoian A, Bălașa R, Huțanu A, Sărmășan E. Moțățăianu A, et al. Int J Mol Sci. 2024 Mar 28;25(7):3782. doi: 10.3390/ijms25073782. Int J Mol Sci. 2024. PMID: 38612591 Free PMC article. - Protective effect of Achyranthes aspera against compound 48/80, histamine and ovalbumin-induced allergic disorders in murine model.
Kaushik A, Singh DP, Sahu M, Kumar A, Pratibha, Pandey P, Patel MK, Chanda D, Sundaresan V, Mani DN, Shukla AK. Kaushik A, et al. Mol Biol Rep. 2024 Jan 25;51(1):202. doi: 10.1007/s11033-023-09137-2. Mol Biol Rep. 2024. PMID: 38270668 - Which inflammatory marker, between systemic immune-inflammation index and neutrophil to eosinophil ratio, is associated with Peyronie's disease and are there any implications for a better understanding of its mechanisms?
Crocetto F, Imbimbo C, Barone B, Turchino D, Bracale UM, Peluso A, Panagrosso M, Falcone A, Mirto BF, De Luca L, Sicignano E, Del Giudice F, Busetto GM, Lucarelli G, Giampaglia G, Manfredi C, Ferro M, Tarantino G. Crocetto F, et al. Basic Clin Androl. 2023 Dec 19;33(1):38. doi: 10.1186/s12610-023-00213-y. Basic Clin Androl. 2023. PMID: 38110896 Free PMC article. - Successful immunosuppressant-free treatment of a drug-induced sarcoidosis-like reaction caused by dupilumab.
Saito S, Shimizu M, Miyashita R, Inoue T, Nagano A, Kunugi S, Hatori T, Okano T, Seike M. Saito S, et al. Respir Med Case Rep. 2023 May 31;44:101883. doi: 10.1016/j.rmcr.2023.101883. eCollection 2023. Respir Med Case Rep. 2023. PMID: 37305219 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources